About
Basic Data Updated:
3 months agoIt is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543434 and on the National Stock Exchange(NSE) under SUPRIYA.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 35.00 cr and a paid-up capital of Rs 16.10 cr.
The Corporate currently has active open charges totaling ₹122.41 cr. It has already closed loans amounting to ₹121.96 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Supriya Lifescience Limited India are Krishna Raghunathan as Cfo, Rajeev Jain as Ceo, and Shweta Singh as Company Secretary. Shivani Wagh, Saloni Wagh, Balasaheb Sawant, and Seven other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
Products or Services related to Supriya Lifescience Limited
Antiallergic API
Financials of Supriya Lifescience Limited
Corporate Structure
Unlock access to Supriya Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Supriya Lifescience Limited
Unlock and access historical data on people associated with Supriya Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
KR
Krishna Raghunathan CFOAppointment Date: 23-Jan-2023
Status: Current
RJ
Rajeev Jain CEOAppointment Date: 03-Oct-2022
Status: Current
SW
Satish Wagh
Managing DirectorAppointment Date: 26-Mar-2008
Status: Current
SS
Shweta Singh Company SecretaryAppointment Date: 26-Aug-2019
Status: Current
Board Members(9)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 May 2021 | ₹48.00 Cr | Open |
The Saraswat Cooperative Bank Ltd Creation Date: 05 Jul 2012 | ₹2.00 Cr | Open |
The Saraswat Cooperative Bank Ltd Creation Date: 27 Jun 2009 | ₹10.91 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supriya Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supriya Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
26 years 28 days 
_PRIVATE_LIMITED.webp)
Recent activity within the organization
Annual General Meeting
Supriya Lifescience Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Balance Sheet
Supriya Lifescience Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge with Others of Rs. 57.00 cr registered on 06 Oct 2008 with Charge ID 10166142 was modified on 18 Nov 2022.
18 Nov 2022Charges
A charge registered on 31 Dec 2019 via Charge ID 100314109 with Others was fully satisfied on 04 Oct 2021.
04 Oct 2021Charges
A charge registered on 01 Oct 2015 via Charge ID 10595222 with The Saraswat Cooperative Bank Ltd was fully satisfied on 04 Oct 2021.
04 Oct 2021
Recent News, Updates & Announcement
Supriya Lifesciences Q3 Results Net profit triples to Rs 30 crore.Revenues rose 33 YoY to Rs 140 crore in Q3FY24 Earnings before interest taxes depreciation and amortisation EBITDA for Q3FY24 almost tripled to reach Rs 4149 crore with an EBITDA margin of 296 in Q3FY24 as opposed to 134 an improvement of 1620 basis points.
Economic Times 08 Feb 2024
Frequently asked questions
What is the Incorporation or founding date of Supriya Lifescience Limited?
